The Patent Finder

Sanochemia Pharmazeutika AG

10 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

3
Ending by 2030
Apr 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Compositions of tolperisone (US 9,315,480) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,662,317Methods of administering tolperisone for therapeutic purposes
In force
 · USPTO record
In forceUSPTO record
US 9,675,598Compositions of tolperisone
In force
 · USPTO record
In forceUSPTO record
US 8,372,979Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
In force
 · USPTO record
In forceUSPTO record
US 9,315,480Compositions of tolperisone
In force
 · USPTO record
In forceUSPTO record
US 10,064,961Method for producing a liquid pharmaceutical preparation
In force
 · USPTO record
In forceUSPTO record
US 9,629,932Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof
In force
 · USPTO record
In forceUSPTO record
US 10,265,397Formulation for photodynamic therapy
In force
 · USPTO record
In forceUSPTO record
US 10,201,609Method for the Production of a Formulation of a Hypericin Salt
In force
 · Low confidence
In forceLow confidence
US 10,143,751Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof
In force
 · USPTO record
In forceUSPTO record
US 12,558,439Process for Producing a Contrast Agent
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 4 lapsed for an unpaid fee · 5 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited